Quantum BioPharma Statistics
Total Valuation
QNTM has a market cap or net worth of $44.10 million. The enterprise value is $38.31 million.
Important Dates
The last earnings date was Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
QNTM has 6.40 million shares outstanding. The number of shares has increased by 136.38% in one year.
| Current Share Class | 6.40M |
| Shares Outstanding | 6.40M |
| Shares Change (YoY) | +136.38% |
| Shares Change (QoQ) | +17.16% |
| Owned by Insiders (%) | 7.29% |
| Owned by Institutions (%) | 9.95% |
| Float | 5.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.63
| Current Ratio | 0.63 |
| Quick Ratio | 0.29 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.25 |
Financial Efficiency
Return on equity (ROE) is -2,056.51% and return on invested capital (ROIC) is -353.44%.
| Return on Equity (ROE) | -2,056.51% |
| Return on Assets (ROA) | -62.38% |
| Return on Invested Capital (ROIC) | -353.44% |
| Return on Capital Employed (ROCE) | 1,047.35% |
| Weighted Average Cost of Capital (WACC) | 9.29% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.83M |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.57% in the last 52 weeks. The beta is 0.36, so QNTM's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | -41.57% |
| 50-Day Moving Average | 4.84 |
| 200-Day Moving Average | 8.86 |
| Relative Strength Index (RSI) | 55.25 |
| Average Volume (20 Days) | 427,336 |
Short Selling Information
The latest short interest is 221,665, so 3.46% of the outstanding shares have been sold short.
| Short Interest | 221,665 |
| Short Previous Month | 282,526 |
| Short % of Shares Out | 3.46% |
| Short % of Float | 3.74% |
| Short Ratio (days to cover) | 0.53 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.87M |
| Pretax Income | -31.97M |
| Net Income | -31.16M |
| EBITDA | -14.33M |
| EBIT | -14.87M |
| Earnings Per Share (EPS) | -$8.22 |
Full Income StatementBalance Sheet
The company has $4.56 million in cash and $870,057 in debt, with a net cash position of $3.69 million or $0.58 per share.
| Cash & Cash Equivalents | 4.56M |
| Total Debt | 870,057 |
| Net Cash | 3.69M |
| Net Cash Per Share | $0.58 |
| Equity (Book Value) | -1.42M |
| Book Value Per Share | 0.10 |
| Working Capital | -5.98M |
Full Balance SheetCash Flow
| Operating Cash Flow | -5.64M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 543,526 |
| Net Borrowing | 2.37M |
| Free Cash Flow | -5.64M |
| FCF Per Share | -$0.88 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
